Empowering Primary Care Physicians With Digital Biomarkers For Early Alzheimer’s Detection

Altoida CEO Mark Jones has high hopes that the company’s digital assessment tool will be approved by the FDA to be used along with blood biomarker testing by primary care doctors to help predict Alzheimer’s disease before patients show symptoms.